Literature DB >> 32757669

The successful use of FLT3 inhibitors in FLT3-positive mixed phenotype acute leukemia.

Claire Andrews1, Wilson Lam2, Hassan Sibai1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32757669     DOI： 10.1080/10428194.2020.1802451

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

Review 1.  Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage.

Authors:  Lindsey E Montefiori; Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2021-10-23       Impact factor: 3.020

Review 2.  Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?

Authors:  Marie C Béné; Anna Porwit
Journal:  Curr Oncol Rep       Date:  2022-04-05       Impact factor: 5.945

3.  Characteristics, Treatment Complexity, and Outcome of Mixed-Phenotype Acute Leukemia in Children in a Low-Middle-Income Country.

Authors:  Maram Salama; Sonia Ahmed; Sonya Soliman; Nahla El-Sharkawy; Sherine Salem; Amr El-Nashar; Reham Khedr; Leslie Lehmann; Iman Sidhom; Alaa El-Haddad
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.